SCHEMBL14469294

SCHEMBL14469294

C=C(N)/C=C(\C=C/N)CN1CCC(C(=O)N2CCN(Cc3c(Cl)cccc3S(=O)(=O)N(C)C)CC2)CC1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.39
▸ POLB P06746 1/20 0.39
▸ TSHR P16473 3/20 0.38
▸ LMNA P02545 1/20 0.38
▸ CYP1A2 P05177 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ ADRB2 P07550 1/20 0.37
▸ KMT2A Q03164 3/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ CA12 O43570 1/20 0.36
▸ CA1 P00915 1/20 0.36
▸ CA2 P00918 1/20 0.36
▸ CA9 Q16790 1/20 0.36
▸ CYP2C19 P33261 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ CNR1 P21554 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14469299 0.91 ALDH1A1 (0.36) ALDH1A1POLBTSHRLMNACYP1A2
SCHEMBL14469365 0.85 KDM4E (0.48) ALDH1A1POLBTSHRLMNASMN1; SMN2
SCHEMBL14469182 0.85 ALDH1A1 (0.48) ALDH1A1POLBTSHRLMNACYP1A2
SCHEMBL14469633 0.84 ALDH1A1 (0.37) ALDH1A1TSHRSMN1; SMN2KMT2AMEN1
SCHEMBL14469197 0.82 CNR1 (0.44) ALDH1A1POLBTSHRLMNASMN1; SMN2
SCHEMBL14469235 0.82 CNR1 (0.45) ALDH1A1POLBSMN1; SMN2KMT2ACNR1
SCHEMBL14469188 0.82 ALDH1A1 (0.46) ALDH1A1POLBTSHRSMN1; SMN2ADRB2
SCHEMBL14469183 0.82 ALDH1A1 (0.39) ALDH1A1POLBTSHRLMNACYP1A2
SCHEMBL14469296 0.80 KMT2A (0.43) ALDH1A1POLBTSHRLMNACYP2C9
SCHEMBL14469193 0.80 POLB (0.43) ALDH1A1POLBTSHRLMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007075555-A2 COMBINATION OF AN H3 ANTAGONIST/INVERSE AGONIST AND AN APPETITE SUPPRESSANT SCHERING CORPORATION (US) 2007-07-05 — — WO disclosed
Send feedback